Latest Automation News

IMEXHS Limited has swung to a profit of $66,200 in 1H FY26, driven by a 17% revenue increase and a surge in underlying EBITDA to $1.27 million. The company’s AI-native radiology platform and Latin American partner expansion underpin growth amid ongoing sector liquidity challenges.

Resonance Health (ASX: RHT) reported a profitable turnaround in FY26, driven by growth across its imaging software, clinical trial services, and site network businesses.

Saluda Medical delivered FY26 revenue of US$90.2 million, beating guidance with strong US and international growth, while reporting a flat net loss of US$149.6 million amid ongoing heavy investment. The company’s FDA approval of its CAP24 paddle lead opens a new US surgical market segment.

Frontier Digital Ventures narrowed its focus to core classifieds, resulting in a 27% revenue decline but an 18% rise in EBITDA and a $2.5 million profit in the first half of 2026.

Talius Group’s HY2026 results reveal a strategic pivot towards higher-margin software subscriptions, with gross margin surging to 51% despite a 19% revenue dip due to hardware deployment timing. Active subscriptions topped 53,200, underpinning a $3.26 million ARR, while cash burn shrank dramatically.

NobleOak Life delivered robust FY26 results with in-force premiums climbing 18% to $549.2 million and underlying NPAT up 15%, driven by strong market share gains and operational efficiency.

McMillan Shakespeare (ASX:MMS) reported a 13.8% rise in underlying net profit after tax and amortisation to $107.9 million for FY26, driven by strong novated lease growth and accelerating electric vehicle adoption.

Acorn Capital Investment Fund Limited posted a 35% drop in profit after tax to $6.25 million for FY2026, while its portfolio outperformed the Small Ords benchmark with a 9.8% return. The company declared fully franked dividends of 3.5 cents per share.

Hubify Limited posted an 89% jump in FY26 EBITDA to $0.66 million despite a 5% revenue dip, driven by a strategic shift to higher-margin managed technology and advisory services and a robust cash position of $3.79 million.

Global Health Limited trimmed its FY26 net loss by 12.5% to A$758,220, driven by a 5.5% lift in recurring SaaS revenue and a 20% cut in employee costs aided by AI integration, though going concern risks remain.

RAS Technology Holdings (ASX:RTH) posted a 34% revenue increase to $28.4 million for FY2026, driven by expansion across all business units and geographic markets including Asia and the UK. Despite this, significant investments in product development and trading capabilities led to a normalized net loss after tax of $0.3 million.

Integrated Research’s FY26 results reveal a sharp 91% drop in net profit amid softer renewals and rising expenses, offset by a 27% jump in cash and a special dividend. The company pushes forward with AI-powered products despite early-stage commercialisation risks.